Linda Chen, MD

About Me

  • Clinical Expertise: Head and Neck Cancer; Brain Cancer and Other Central Nervous System Tumors; Metastatic Brain Tumors and Secondary Brain Cancer; Gastrointestinal Cancers; Intensity-Modulated Radiation Therapy (IMRT); Image-guided radiation therapy (IGRT); Stereotactic Body Radiation Therapy (SBRT); Stereotactic Radiosurgery (SRS)
  • Awards and Honors: Radiological Society of North America (RSNA) Roentgen Research Award (2018); Chief Resident, Resident Research and Education (2017-2018); American Society of Radiation Oncology (ASTRO) Biology Abstract Award (2017); Johns Hopkins Physician Scientist Training Program Grant Recipient (2017); AACR Molecular Biology in Clinical Oncology Workshop Fellow (2017); AACR/ASCO Methods in Clinical Cancer Research Workshop Fellow (2016)
  • Languages Spoken: English
  • Education: MD, Duke University School of Medicine
  • Residencies: Radiation Oncology - Johns Hopkins University


Visit PubMed for a full listing of Linda Chen’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.